Evidence map›Paper›PMID 19328213›Full record

ReviewBrain research reviews2009

Methamphetamine toxicity and messengers of death.

Irina N Krasnova, Jean Lud Cadet

Abstract readReview
In one paragraph

Review in Brain research reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 282 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
282citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

282 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  8. Article
  9. Cocaine abuse and its impact on the thymus and spleen.Histology and histopathology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

222 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Irina N KrasnovaMolecular Neuropsychiatry Research Branch, Intramural Research Program, NIDA/NIH/DHHS, Baltimore, MD 21224, USA.
Jean Lud Cadet

Funding

Neurotoxicity in the adult rat following chronic exposure to methamphetamineZIADA000552 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CADET, JEAN LUD · 2009 to 2025
$34.3M
Protective effects of DA antagonists Vs METH induced toxicity in ratsZIADA000551 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CADET, JEAN LUD · 2009 to 2016
$4.7M
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the MouseZIADA000494 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CADET, JEAN LUD · 2009 to 2011
$1.0M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter and microgliosis in different brain areas. In the present review, we summarize data on the animal models of METH neurotoxicity which include degeneration of monoaminergic terminals and neuronal apoptosis. In addition, we discuss molecular and cellular bases of METH-induced neuropathologies. The accumulated evidence indicates that multiple events, including oxidative stress, excitotoxicity, hyperthermia, neuroinflammatory responses, mitochondrial dysfunction, and endoplasmic reticulum stress converge to mediate METH-induced terminal degeneration and neuronal apoptosis. When taken together, these findings suggest that pharmacological strategies geared towards the prevention and treatment of the deleterious effects of this drug will need to attack the various pathways that form the substrates of METH toxicity.

Indexed as

Neurotoxicity SyndromesAnimalsBlood-Brain BarrierBody Temperature RegulationCell DeathCentral Nervous SystemCentral Nervous System StimulantsDNA DamageHumansMethamphetamineReceptors, DopamineSubstance-Related DisordersCentral Nervous System StimulantsMethamphetamineReceptors, Dopamine

Identifiers

PMID19328213
PMCPMC2731235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.